Suchergebnisse
Suchergebnisse:
Tasuku Honjo ist ein japanischer Immunologe, der für Forschungen über die molekularbiologischen Ursachen der Antikörper-Diversität und neue immunologische Ansätze in der Krebstherapie bekannt ist. 2018 wurde ihm zusammen mit James P. Allison der Nobelpreis für Physiologie oder Medizin zuerkannt.
Tasuku Honjo (本庶 佑, Honjo Tasuku, born January 27, 1942) is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1).
1. Okt. 2018 · Press release. 2018-10-01. The Nobel Assembly at Karolinska Institutet. has today decided to award. the 2018 Nobel Prize in Physiology or Medicine. jointly to. James P. Allison and Tasuku Honjo. for their discovery of cancer therapy by inhibition of negative immune regulation.
Tasuku Honjo is a distinguished professor and deputy director-general of KUIAS, and a Nobel laureate in medicine for his discovery of PD-1. He has also made significant contributions to molecular immunology, class switch recombination, and cancer immunotherapy.
1. Okt. 2018 · Der Amerikaner James P. Allison und der Japaner Tasuku Honjo erhalten den diesjährigen Nobelpreis für Medizin oder Physiologie. Das gab die Nobelversammlung des Karolinska-Instituts in...
1. Okt. 2018 · Tasuku Honjo and James Allison share the 2018 Nobel Prize in Physiology or Medicine for discovering how to unleash the immune system to attack cancer cells. They studied different proteins that act as brakes on T cells, leading to the development of drugs that have extended survival in some patients.
Learn about the life and achievements of Tasuku Honjo, who discovered PD-1 and revolutionized cancer immunotherapy. He is a professor at Kyoto University and a former president of Shizuoka University and FBRI.
